Compare Monolithic Power Systems Inc (MPWR) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monolithic Power Systems Inc vs TransMedics Group Inc — how do they compare? Monolithic Power Systems Inc trades at $1,423.5 (market cap $68.90B), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: Monolithic Power Systems Inc is far larger — about 22.2× TransMedics Group Inc's market cap, and Monolithic Power Systems Inc pays a 0.57% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| MPWR | TMDX | |
|---|---|---|
Market Cap | $68.90B | $3.10B |
Sector | Utilities | Technology |
52-Week High | $1.69K | $150.42 |
52-Week Low | $820.74 | $61.99 |
Enterprise Value | $67.51B | $3.49B |
Dividend Yield | 0.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
